2 Beaten-Down Biotech Stocks: Are They Bargains Now?
17/8 12:31
It isn't easy being a drugmaker without any drugs to sell. As shareholders of these two biotech stocks have learned recently, it isn't easy to own shares of clinical-stage drugmakers, either. Shares of these formerly high-flying biotech stocks crashed this year in response to se...